Immunosuppression in Pediatric Heart Transplantation-The Leaner the Better?

Tim Attmann^{1

2}, Anselm Uebing^{2

3}, Stephan M Ensminger^{2

4}

Affiliations

¹ Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.
² DZHK (German Center for Cardiovascular Research), Partner-Site Hamburg/Kiel/Lübeck, Germany.
³ Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.
⁴ Department of Cardiac and Thoracic Vascular Surgery, University Heart Center Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany.

Comment

Tim Attmann et al. Transplantation. 2024.

. 2024 Jan 1;108(1):e1-e2.

doi: 10.1097/TP.0000000000004821. Epub 2023 Oct 2.

Tim Attmann^{1

2}, Anselm Uebing^{2

3}, Stephan M Ensminger^{2

4}

¹ Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.
² DZHK (German Center for Cardiovascular Research), Partner-Site Hamburg/Kiel/Lübeck, Germany.
³ Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.
⁴ Department of Cardiac and Thoracic Vascular Surgery, University Heart Center Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany.

No abstract available

Comment on

Medium-term Outcomes in Pediatric Heart Transplant Recipients Managed Using a Steroid Avoidance Immune Suppression Protocol.
Hartje-Dunn C, Blume ED, Bastardi H, Daly KP, Fynn-Thompson F, Gauvreau K, Singh TP. Hartje-Dunn C, et al. Transplantation. 2024 Jan 1;108(1):e8-e14. doi: 10.1097/TP.0000000000004820. Epub 2023 Oct 2. Transplantation. 2024. PMID: 37788365

1. Singh TP, Cherikh WS, Hsich E, et al.; International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-fourth pediatric heart transplantation report—2021; focus on recipient characteristics. J Heart Lung Transplant. 2021;40:1050–1059.
1. Van Sandwijk MS, Bemelman FJ, Ten BergeI J. Immunosuppressive drugs after solid organtransplantation. Neth J Med. 2013;71:281–289.
1. Irving CA, Webber SA. Immunosuppression therapy for pediatric heart transplantation. Curr Treat Options Cardiovasc Med. 2010;12:489–502.
1. Hartje-Dunn C, Blume ED, Bastardi H, et al. Medium term outcomes in pediatric heart transplant recipients managed using a steroid avoidance immune suppression protocol. Transplantation. 2024;108:e8–e14.
1. Watelle L, Touré M, Lamour JM, et al. Single-drug immunosuppression is associated with noninferior medium-term survival in pediatric heart transplant recipients. J Heart Lung Transplant. 2023;42:1074–1081.